SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Fund declared regular distributions to shareholders on August 20, 2026, with a per-share amount of $0.20 for Class I shares, record date of August 31, 2026, and payment date on or about September 30, 2026.
View raw filing on EDGAR →Audax Private Credit Fund issued 1,718,450.952 limited liability company interests for $42.2 million on July 1, 2026, to accredited investors and non-U.S. persons pursuant to subscription agreements exempt from Securities Act registration under Section 4(a)(2) and Regulations D/S.
View raw filing on EDGAR →The Fund disclosed its net asset value (NAV) per share as of June 30, 2026, including aggregate NAV, portfolio fair value, and debt-to-equity ratio, reflecting the Fund's financial position and per-share value.
View raw filing on EDGAR →The disclosure announces RBI approval for Life Insurance Corporation of India to acquire up to 9.99% of HDFC Bank's paid-up share capital or voting rights. While this involves a significant shareholding change (LIC currently holds 4.11%), it is a regulatory approval of a potential acquisition rather than a completed M&A transaction or a discrete governance event like an executive appointment or compensation arrangement. The event is material to investors as it signals a major potential shareholder change and regulatory clearance, but does not fit neatly into the M&A taxonomy (which typically covers completed transactions or binding agreements) or other specific categories, making it a governance-related disclosure of regulatory significance.
View raw filing on EDGAR →The filing discloses the Board of Directors' approval of a quarterly cash dividend of $0.90 per share on outstanding common stock, payable October 1, 2026 to shareholders of record as of September 10, 2026. This is a straightforward dividend declaration that would be material to shareholders and investors assessing the company's capital allocation and shareholder returns.
View raw filing on EDGAR →The filing discloses the appointments of Jorge J. García as President and Chief Executive Officer and Lidio V. Soriano as Executive Vice President and Chief Financial Officer, both effective September 1, 2026. While the section also details compensatory arrangements (base salary, incentive targets, and a one-time promotion award), the principal disclosed action centers on the executive appointments themselves. The appointments of a CEO and CFO are material events affecting the registrant's leadership structure and governance.
View raw filing on EDGAR →The filing discloses the Company's Net Asset Value (NAV) per share as of July 31, 2026, broken down by share class and with detailed component analysis. This is a routine but material financial disclosure for a non-traded REIT, as NAV per share is the primary valuation metric for investors in such vehicles and directly affects pricing for subscriptions and redemptions. The disclosure does not fit a more specific financial event type (not earnings, debt, dividend, impairment, or restatement), making financial_other the appropriate classification.
View raw filing on EDGAR →The registrant announced a cash dividend declaration of $0.17 per common share payable September 17, 2026, representing a 6% increase from the prior quarter. This is a routine but material shareholder distribution event that affects investor returns and reflects management confidence in financial condition and earnings capacity.
View raw filing on EDGAR →The disclosure centers on the appointment of Matthew D. Murphy as interim Treasurer and Chief Financial Officer effective September 15, 2026, following Diego Reynoso's departure. While the section discloses both a departure and an appointment, the principal action is Murphy's appointment to a critical executive role (CFO/Treasurer). The compensation details (base salary unchanged at $419,359.41, bonus target 50%, equity target $250,000, and a $700,000 transition bonus) are ancillary to the appointment itself and do not rise to the level of a standalone exec_compensation event, which typically involves material changes to compensation arrangements or shareholder approval of compensation plans.
View raw filing on EDGAR →SLR HC BDC LLC entered into a new Loan Financing and Servicing Agreement (DB Credit Facility) with Deutsche Bank AG on August 14, 2026, creating a $35 million credit facility with $29 million borrowed at closing to refinance and replace an existing JPMorgan credit facility. The transaction involves a five-year maturity and specified interest rate terms, materially affecting the company's capital structure and financial obligations.
View raw filing on EDGAR →On August 14, 2026, 26North BDC amended its Loan and Security Agreement (Subscription Facility), extending the maturity date to August 13, 2027, increasing the Advance Rate, and adding new covenants. This amendment materially modifies the Company's direct financial obligations by extending maturity and increasing borrowing capacity.
View raw filing on EDGAR →This exhibit is a press release announcing Huize's unaudited financial results for the first half of 2026 (six months ended June 30, 2026). It discloses key financial metrics including GWP of RMB4,196.4 million (up 29.8% YoY), operating revenue of RMB719.8 million (up 5.8% YoY), and net profit attributable to common shareholders of RMB25.3 million. The document includes condensed consolidated balance sheets and statements of comprehensive income, along with management commentary. This is a discrete earnings announcement, not a periodic financial report filing itself, and is material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →Werewolf Therapeutics entered into a material asset purchase agreement with EMD Serono on August 14, 2026, selling its INDUCER and INDUKINE platforms for $28.0 million upfront plus $5.0 million upon technology transfer completion. This constitutes a material disposition of assets under Item 1.01, with significant intellectual property and pre-clinical compounds transferred, while the company retains development rights for WTX-124 and WTX-330 clinical programs through a concurrent exclusive license agreement.
View raw filing on EDGAR →Flowers Foods issued a press release on August 20, 2026 announcing its financial results for the 12-week second quarter ended July 18, 2026, disclosing net sales of $1.193 billion (down 4.0%), net income of $40.7 million (down 30.3%), and diluted EPS of $0.19 (down $0.09). The filing also includes revised full-year 2026 guidance with lower net sales and earnings expectations. This is a standard quarterly earnings release under Item 2.02, material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →Allison Spector resigned from the Company's Board of Directors effective August 18, 2026, following a decrease in ownership by the ORCP Stockholders. The disclosure explicitly states the resignation and its effective date, and notes the Board size reduction to ten directors. While the resignation is contractually triggered by ownership changes rather than a disagreement, it remains a material director departure requiring disclosure under Item 5.02.
View raw filing on EDGAR →QNB Corp. completed a registered public offering of 1,232,142 shares of common stock at $42.00 per share (including the full exercise of the underwriters' 30-day overallotment option), generating approximately $48.3 million in net proceeds. The offering will be used for balance sheet restructuring, subordinated note redemption, and capital support, and materially dilutes existing shareholders' ownership and voting power.
View raw filing on EDGAR →ICE completed a public offering of $3.75 billion in aggregate principal amount of senior notes across four tranches (due 2029, 2031, 2033, and 2036), generating approximately $3.71 billion in net proceeds. The disclosure explicitly states the notes were issued under an Underwriting Agreement and Supplemental Indenture, creating new direct financial obligations. While the proceeds are earmarked for the MarketAxess acquisition, the primary event disclosed here is the debt issuance itself, which is material to investors assessing ICE's capital structure and leverage.
View raw filing on EDGAR →Goldman Sachs Private Credit Corp. completed an unregistered sale of equity securities totaling approximately $155.7 million across Class I, S, and D shares pursuant to Section 4(a)(2), Regulation D, and/or Regulation S exemptions to accredited investors and non-U.S. persons.
View raw filing on EDGAR →The Board of Directors declared a regular monthly distribution on May 6, 2026, with per-share amounts of $0.1850 for Class I, $0.1675 net for Class S, and $0.1799 net for Class D shares, payable on or about August 28, 2026.
View raw filing on EDGAR →The Company reported its Net Asset Value as of July 31, 2026 of $9.4 billion total ($24.59 per share across all classes), investment portfolio fair value of $18.0 billion, and fund leverage of 0.9x.
View raw filing on EDGAR →EIDP, Inc. disclosed a material separation of Corteva, Inc. into two independent publicly traded companies—one retaining the crop protection business and the other (Vylor) acquiring the seed business. In connection with this separation, EIDP entered into the Fourth EIDP Supplemental Indenture and concurrent Exchange Offers and Consent Solicitations to restructure its debt obligations, constituting a material change of control and disposition event.
View raw filing on EDGAR →The filing discloses multiple executive appointments and promotions effective August 20, 2026: Tom Hellman to EVP Exploration & Production (Anadarko, Eagle Ford, Marcellus, Rockies), Trey Lowe III to EVP Exploration & Production (Permian), and Kevin Smith to EVP and Chief Technology Officer. While two departures are also mentioned (John Raines and Michael DeShazer effective September 1, 2026), the principal disclosed action centers on the three new appointments and role transitions, making exec_appointment the most salient classification. The changes affect senior leadership in core E&P operations at a major energy company.
View raw filing on EDGAR →LivePerson held a special stockholder meeting on August 20, 2026, to vote on the proposed merger with SoundHound AI. The Adjournment Proposal was approved with 5,811,286 shares in favor versus 193,675 against, and the meeting was adjourned to September 2, 2026, to solicit additional proxies for the Merger Proposal, which had received over 97% support to date.
View raw filing on EDGAR →LivePerson is pursuing a material merger with SoundHound AI, with a special stockholder meeting held on August 20, 2026, to vote on adoption of the Amended and Restated Merger Agreement. The meeting was adjourned to September 2, 2026, to allow additional shareholders to vote and reach the required majority threshold.
View raw filing on EDGAR →Personalis received a new $18.3 million task order under its VA Million Veteran Program contract, bringing cumulative task order value to $243.3 million. This is a material contract milestone and revenue-generating operational event that would affect investor assessment of the company's business prospects and revenue pipeline, but does not fit the specific categories of M&A, debt issuance, impairment, or other defined event types. It is clearly operational in nature.
View raw filing on EDGAR →First Eagle Private Credit Fund declared regular distributions to shareholders of $0.210 per share (gross) for both Class I and Class D common shares, with a record date of August 31, 2026 and payment date of September 29, 2026.
View raw filing on EDGAR →The exhibit announces the dismissal of PricewaterhouseCoopers Zhong Tian LLP and engagement of KPMG Huazhen LLP as the Company's independent registered public accounting firm, effective August 19, 2026. This is a clear auditor change event. The disclosure explicitly states there were no disagreements on accounting principles or practices, and no reportable events other than a previously disclosed material weakness, indicating a routine auditor transition rather than a crisis-driven change.
View raw filing on EDGAR →This disclosure describes entry into an underwriting agreement for a public offering of 14.09 million shares of common stock at $35.50 per share, generating approximately $471.7 million in net proceeds (or $542.5 million if the option is exercised). While the event is clearly material and involves a definitive agreement under Item 1.01, the core transaction is an equity issuance, not a debt issuance. The taxonomy lacks a specific "equity_issuance" or "public_offering" category; `debt_issuance` is the closest fit for creation of a direct financial obligation, though it is technically misaligned with the equity nature of this transaction.
View raw filing on EDGAR →The exhibit announces a favorable U.S. Court of Appeals ruling that vacated the Department of Transportation's order terminating the Aeromexico-Delta joint venture and its antitrust immunity. This is a material legal/regulatory victory that preserves a significant commercial arrangement and competitive position. While not a traditional litigation settlement or judgment, it is a material court decision affecting the registrant's ability to operate a key strategic partnership, making it a legal event that does not fit the specific litigation category but clearly belongs in the legal domain.
View raw filing on EDGAR →Rising Dragon Acquisition Corp. received a written notice from Nasdaq on August 19, 2026, that its Market Value of Listed Securities fell below the $35 million minimum required for continued listing on the Nasdaq Capital Market. The company has 180 calendar days (until February 16, 2027) to regain compliance; failure to do so will result in delisting. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the registrant's continued exchange listing status.
View raw filing on EDGAR →The press release announces Solmate's acquisition of approximately 1,000 SOL tokens, bringing total holdings to 1.25M SOL with an estimated market value of $102.2M as of August 20, 2026. This represents a material capital deployment and treasury position update that would affect a reasonable investor's assessment of the company's financial position and asset holdings. While not fitting a discrete event category like debt issuance or M&A, it is a significant financial event involving the company's core digital asset accumulation strategy and treasury management.
View raw filing on EDGAR →The filing discloses a proposed business combination between HeartSciences and Fortitude Mining Holdings, Inc., with a definitive Merger Agreement entered into on June 23, 2026, and expected to close in H2 2026. The press release also reports Fortitude's $1 million investment in HeartSciences common stock (411,522 shares at $2.43/share), giving Fortitude approximately 9.4% ownership. This is a material acquisition/change-of-control transaction that would bring Fortitude to public markets via HeartSciences' NASDAQ listing, directly impacting the registrant's capital structure and strategic direction.
View raw filing on EDGAR →This announcement discloses a positive Data Safety and Monitoring Committee (DSMC) recommendation to advance the Phase 1 HEAT clinical trial of 177Lu-RAD202 to Cohort 4 at a higher dose level (180mCi) in HER2-positive advanced solid tumors. This represents a material clinical development milestone for a clinical-stage biopharmaceutical company's lead therapeutic candidate, demonstrating favorable safety and supporting progression to the next dose level. While not a discrete event type like M&A or exec change, this is a significant operational/clinical milestone that would affect a reasonable investor's assessment of the company's pipeline progress and de-risking of its most promising asset.
View raw filing on EDGAR →The filing discloses a shareholder meeting scheduled for August 25, 2026, to vote on approval of a proposed business combination between Bleichroeder Acquisition Corp. II and Pasqal Holding SAS. The press release and Item 8.01 disclosure confirm the parties are "advancing toward completion of the previously announced transaction" following SEC effectiveness of the joint F-4 registration statement on August 5, 2026. This is a material M&A event—a SPAC merger with a quantum computing company—that requires shareholder approval and would materially affect the registrant's business and capital structure.
View raw filing on EDGAR →The disclosure centers on four executive personnel appointments effective August 20, 2026: Evan H. Jenkins promoted to Chief Administrative Officer (retaining Vice Chair and Secretary roles), J. Tyler Adkins promoted to General Counsel (retaining Assistant Secretary), Tyler H. Fields promoted to Assistant General Counsel, and Cameron H. Adkins hired as Director of Law, Finance, and Operations. These are material appointments to key leadership and legal positions that would affect investor assessment of the company's governance and operational structure.
View raw filing on EDGAR →The press release discloses receipt of a Nasdaq Listing Qualifications Staff Determination Letter on August 18, 2026, notifying the Company that it has failed to maintain the minimum bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). The Company has been granted a 180-calendar-day compliance period (until February 16, 2027) to regain compliance, with potential for an additional 180-day period if certain conditions are met. This is a material delisting risk disclosure under Item 3.01 equivalent, as it directly threatens the Company's continued listing on Nasdaq and would significantly affect investor assessment of the registrant's status and trading liquidity.
View raw filing on EDGAR →The filing discloses Q2 2026 financial results for the quarter ended June 30, 2026, including cash on hand ($719,000), total assets ($1.0 million), current liabilities ($28.2 million), stockholders' deficit of $(27.1) million, and net losses of $(8.8) million (Q2) and $(12.2) million (six months). The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. While the release also discusses progress on the G3 acquisition option agreement, the primary disclosure is the quarterly financial results.
View raw filing on EDGAR →Garden Stage Ltd is soliciting shareholder votes at an Extraordinary General Meeting (scheduled August 26, 2026) on four resolutions: increase in authorized share capital from US$50,000 to US$1,000,000, adoption of third amended and restated memorandum and articles of association, authorization of transfer agent and registrar to update records, and adjournment authority. The proposed increase in authorized capital is material to investors as it could enable significant dilution.
View raw filing on EDGAR →The 6-K discloses results of an Extraordinary General Meeting of Shareholders held on August 20, 2026, with voting outcomes on three proposals: (1) a 50-for-1 share consolidation and corresponding changes to authorized capital, (2) adoption of sixth amended and restated memorandum and articles of association reflecting the consolidation and governance amendments, and (3) adjournment authority. All three proposals were approved by shareholders with substantial majorities. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the share consolidation is material to investors as it fundamentally alters share structure and par value.
View raw filing on EDGAR →This is a shareholder letter disclosing the Company's product redesign (GameGolf KZN AI platform), commercial launch timeline (end of September 2026), pricing model ($299.99 device + $119.88 annual subscription), market opportunity, and strategic roadmap including expansion beyond golf. While the letter contains forward-looking statements about product capabilities and market expansion, it is fundamentally an operational and strategic disclosure about the Company's business model, product offerings, and commercialization progress—not a specific financial, governance, or legal event. The disclosure is material as it provides investors with substantive information about the Company's core business strategy and near-term execution plans following its recent IPO (S-1 effective July 28, 2026).
View raw filing on EDGAR →The 6-K discloses a board-approved reverse stock split at a 1-for-15 ratio, effective August 24, 2026, implemented to comply with Nasdaq's minimum bid price requirement and to position the company for a potential institutional transaction. This is a governance/capital structure event that materially affects shareholders' holdings and the company's compliance status, though it does not fit the specific named categories (exec appointment/departure, compensation, M&A, etc.). The governance domain is clear; `governance_other` is the appropriate classification.
View raw filing on EDGAR →Treasure Global Inc entered into two material definitive Sale and Purchase Agreements on August 20, 2026, disposing of equity interests in V Gallant Limited (1,300,000 shares for USD 5.2 million) and Reveillon Group Limited (700,000 shares for USD 1.4 million) to separate purchasers, totaling USD 6.6 million in dispositions.
View raw filing on EDGAR →This is a press release announcing BOS's second quarter and first half 2026 financial results, including revenue of $14.9 million (Q2, up 29% YoY), net income of $1.4 million per diluted share ($0.19), and raised full-year 2026 net income guidance to exceed $3.6 million. The exhibit contains consolidated statements of operations, balance sheets, and segment information, all hallmarks of a quarterly earnings disclosure material to investors.
View raw filing on EDGAR →This press release announces completion of clinical site contracting for Polyrizon's NASARIX™ first-in-human clinical trial and advancement toward patient enrollment. As a development-stage biotech company, this represents a material operational and strategic milestone in advancing its lead product toward commercialization. The disclosure describes concrete progress (all five U.S. clinical sites contracted, 120-patient trial design, primary and secondary endpoints defined) that would affect a reasonable investor's assessment of the company's clinical development trajectory and near-term execution capability.
View raw filing on EDGAR →The filing discloses both the departure of Thomas D. Schwenger (President and Chief Customer Officer since 2019) and the appointment of Dan Rizzo as EVP, Sales, Consulting, and Services, effective October 2, 2026. While both events occur, the principal action emphasized in the announcement is the appointment of Rizzo to fill the senior leadership role vacated by Schwenger's departure. The appointment of a named executive to a significant officer position is the salient disclosed event, making exec_appointment the most appropriate classification.
View raw filing on EDGAR →EZGO Technologies entered into a securities purchase agreement on August 5, 2026, to issue 3,000,000 ordinary shares at US$0.50 per share for aggregate gross proceeds of US$1.5 million in a private investment in public equity (PIPE) transaction. The shares were issued on August 19, 2026, and were offered in reliance on Regulation S exemption from registration. This is a classic dilutive equity issuance that would materially affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →The Company entered into a Share Exchange and Investment Agreement on August 19, 2026, whereby it issued 1,500,000 Class A ordinary shares valued at US$4,050,000 in exchange for a 5.06% equity interest in Qifei (Shanghai) Technology Co., Ltd., a target company engaged in intelligent systems and AI solutions. This constitutes a material acquisition or investment activity under Item 1.01 / 2.01 equivalent, with strategic complementarity to the Company's existing AI operations and a substantial consideration amount.
View raw filing on EDGAR →This is a Business Separation Agreement dated August 17, 2026, between VCI Global Limited and V Gallant Limited, documenting the separation of VCI's Technology-Related Business (AI, cybersecurity, robotics, cloud storage, hardware/software) into a spin-off subsidiary. The agreement establishes transition services, representations and warranties, closing conditions, and non-competition covenants. This constitutes a material change of control and disposition of a significant business segment, triggering disclosure under Item 1.01 or 2.01 of Form 8-K (or equivalent 6-K disclosure for a foreign private issuer).
View raw filing on EDGAR →Virtuix Holdings Inc. issued a press release on August 19, 2026 announcing financial results for the first quarter of fiscal year 2027 ended June 30, 2026, disclosing net sales of $0.8 million, gross profit of $227,158 (30% margin), and net loss of $7.2 million (EPS of ($0.22)), along with operational highlights including 72% year-over-year order growth and 29% gross profit increase.
View raw filing on EDGAR →This 6-K furnishes a clarification regarding an Extraordinary General Meeting of Shareholders scheduled for August 21, 2026, to vote on a 1-for-40 share consolidation. The filing clarifies that while the shareholder meeting will proceed as scheduled, the marketplace effective date of the consolidation on Nasdaq will be determined later in coordination with Nasdaq, DTC, and the transfer agent. This is a governance event (shareholder meeting and capital structure matter) that does not fit the specific `shareholder_vote_results` category (which applies to results *after* a vote), but rather is a procedural clarification ahead of the vote. The share consolidation is material to investors as it affects share structure and trading mechanics.
View raw filing on EDGAR →